Cure JM offers grant funding for clinicians and researchers who are working to improve juvenile myositis care and advance research.use of harsher treatments like prednisone and methotrexate
The 2024 grant cycle saw a strong field of new, progressive research projects from world-class researchers across the globe. The field of engaged, leading JM researchers continues to grow with studies in new targeted drug discovery and new biomarkers to more precisely predict flares, and brain development in inflammatory diseases.
We hope that by developing new treatments, patients of all ages will be able to reduce the use of harsher treatments like prednisone and methotrexate.
This year’s successful grantees span the development of new drugs and a new class of drugs for JM. Other grantees included investigating genetic/genomic signals and their correlation to a predisposition to JM and new screening strategies to determine which drugs have efficacy in JM. Each successful grantee for 2022 has provided a lay scientific summary and discussed their journey in JM research and the impact a Cure JM grant will have on their research programs.
To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.